X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (249) 249
humans (238) 238
index medicus (189) 189
prostate cancer (174) 174
orchiectomy (168) 168
oncology (156) 156
mitoxantrone plus prednisone (149) 149
prostatic neoplasms - drug therapy (143) 143
docetaxel (113) 113
chemotherapy (111) 111
prostatic neoplasms - pathology (95) 95
urology & nephrology (90) 90
cancer (87) 87
prostatic neoplasms - surgery (83) 83
aged (79) 79
care and treatment (72) 72
antineoplastic agents - therapeutic use (68) 68
middle aged (67) 67
androgen antagonists - therapeutic use (65) 65
treatment outcome (65) 65
abiraterone acetate (59) 59
antineoplastic combined chemotherapy protocols - therapeutic use (58) 58
metastasis (56) 56
prostatic neoplasms - therapy (54) 54
survival (51) 51
prostate-specific antigen - blood (50) 50
taxoids - therapeutic use (49) 49
aged, 80 and over (48) 48
prostatic neoplasms - mortality (45) 45
research (45) 45
animals (43) 43
double-blind (42) 42
castration-resistant prostate cancer (41) 41
neoplasm metastasis (41) 41
taxoids - administration & dosage (40) 40
antineoplastic agents, hormonal - therapeutic use (39) 39
antitumor-activity (38) 38
pharmacology & pharmacy (38) 38
drug therapy (36) 36
plus prednisone (36) 36
disease progression (35) 35
immunotherapy (35) 35
therapy (35) 35
carcinoma (34) 34
health aspects (34) 34
phase-ii trial (33) 33
prostatic neoplasms - blood (33) 33
phase-iii trial (32) 32
radical prostatectomy (32) 32
prognosis (31) 31
clinical trials as topic (30) 30
sipuleucel-t (30) 30
abiraterone (29) 29
clinical trials (29) 29
clinical-trials (29) 29
drug resistance, neoplasm (29) 29
androgens (28) 28
development and progression (28) 28
increased survival (28) 28
trial (28) 28
androgen-deprivation therapy (27) 27
survival analysis (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
cabazitaxel (26) 26
castration (26) 26
randomized controlled-trial (26) 26
urology (26) 26
cancer therapies (25) 25
combined modality therapy (24) 24
men (24) 24
adult (23) 23
antineoplastic agents - adverse effects (23) 23
androgen receptor (22) 22
article (22) 22
female (22) 22
oncology, experimental (22) 22
randomized controlled trials as topic (22) 22
androstenes (21) 21
neoplasm staging (21) 21
neoplasms, hormone-dependent - drug therapy (21) 21
patient outcomes (21) 21
bone neoplasms - secondary (20) 20
disease-free survival (20) 20
estramustine (20) 20
retrospective studies (20) 20
review (20) 20
survival rate (20) 20
antiandrogen withdrawal (19) 19
hematology, oncology and palliative medicine (19) 19
medicine, general & internal (19) 19
mitoxantrone (19) 19
quality-of-life (19) 19
androstenols - therapeutic use (18) 18
antineoplastic agents - administration & dosage (18) 18
drug administration schedule (18) 18
prednisone - administration & dosage (18) 18
prostate (18) 18
prostatectomy (18) 18
radiotherapy (18) 18
randomized phase-ii (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Urology, ISSN 0090-4295, 1995, Volume 46, Issue 2, pp. 220 - 226
To compare the efficacy and safety of goserelin and orchiectomy in patients with Stage D2 prostate cancer. A randomized, open, multicenter study was conducted... 
PROGNOSTIC FACTORS | ZOLADEX | NILUTAMIDE | DES | PLUS FLUTAMIDE | UROLOGY & NEPHROLOGY | DISEASE FLARE | CARCINOMA | Clinical trials | Goserelin
Journal Article
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 6, Issue 6, p. CD009266
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 760 - 768
Journal Article